Transcatheter Valve Innovations for Congenital Patients with Dr. Stephen Nageotte

In this video, Dr. Stephen Nageotte of the Guerin Family Congenital Heart Program at Cedars-Sinai discusses how transcatheter technologies are expanding treatment options for people with congenital heart valve disease. He explains the growing role of self-expanding valves in pulmonary valve replacement, emerging innovation involving the tricuspid valve, and why patients benefit from care provided by a comprehensive heart team.

Dr. Nageotte also explains why congenital heart valve treatment requires long-term planning from the very first intervention. Choosing the right initial procedure can help prepare patients for future valve-in-valve treatments and support successful lifetime management as they move from childhood and adolescence into adulthood. (Video posted on August 5, 2026)